• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Rev Nephrol . Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions

tetano

Editor, Senior Moderator
Nat Rev Nephrol


. 2022 Aug 24.
doi: 10.1038/s41581-022-00618-4. Online ahead of print.
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions


Duvuru Geetha[SUP] #[/SUP][SUP] 1 [/SUP], Andreas Kronbichler[SUP] #[/SUP][SUP] 2 [/SUP], Megan Rutter[SUP] 3 [/SUP], Divya Bajpai[SUP] 4 [/SUP], Steven Menez[SUP] 5 [/SUP], Annemarie Weissenbacher[SUP] 6 [/SUP], Shuchi Anand[SUP] 7 [/SUP], Eugene Lin[SUP] 8 9 [/SUP], Nicholas Carlson[SUP] 10 11 [/SUP], Stephen Sozio[SUP] 5 [/SUP], Kevin Fowler[SUP] 12 [/SUP], Ray Bignall[SUP] 13 [/SUP], Kathryn Ducharlet[SUP] 14 15 [/SUP], Elliot K Tannor[SUP] 16 17 [/SUP], Eranga Wijewickrama[SUP] 18 19 [/SUP], Muhammad I A Hafiz[SUP] 20 [/SUP], Vladimir Tesar[SUP] 21 [/SUP], Robert Hoover[SUP] 22 [/SUP], Deidra Crews[SUP] 5 [/SUP], Charles Varnell[SUP] 23 24 25 [/SUP], Lara Danziger-Isakov[SUP] 26 [/SUP], Vivekanand Jha[SUP] 27 28 29 [/SUP], Sumit Mohan[SUP] 30 [/SUP], Chirag Parikh[SUP] 5 [/SUP], Valerie Luyckx[SUP] 31 32 33 [/SUP]



Affiliations

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has disproportionately affected patients with kidney disease, causing significant challenges in disease management, kidney research and trainee education. For patients, increased infection risk and disease severity, often complicated by acute kidney injury, have contributed to high mortality. Clinicians were faced with high clinical demands, resource shortages and novel ethical dilemmas in providing patient care. In this review, we address the impact of COVID-19 on the entire spectrum of kidney care, including acute kidney injury, chronic kidney disease, dialysis and transplantation, trainee education, disparities in health care, changes in health care policies, moral distress and the patient perspective. Based on current evidence, we provide a framework for the management and support of patients with kidney disease, infection mitigation strategies, resource allocation and support systems for the nephrology workforce.
 
Back
Top Bottom